創立于1999年,主打諾迪康膠囊及十味蒂達膠囊,集藏藥/植物藥/化學藥/生物制品等的研制銷售為一體的制藥企業
西藏(zang)諾迪(di)康藥(yao)業股份有限公司于1999年7月(yue)(yue)14日(ri)在西藏(zang)自治區(qu)創(chuang)立(li),1999年7月(yue)(yue)21日(ri)在上(shang)(shang)海(hai)證券交易所上(shang)(shang)網交易,是一家高新(xin)技術制藥(yao)上(shang)(shang)市(shi)企業,股票(piao)名稱(cheng):西藏(zang)藥(yao)業,股票(piao)代碼:600211。
公司秉承“科(ke)學(xue)成(cheng)就(jiu)健(jian)(jian)康,健(jian)(jian)康成(cheng)就(jiu)未來”的理念,以科(ke)技興業。在為藏(zang)(zang)藥(yao)(yao)(yao)現代化不遺余力的同時,注巨資于(yu)生物制(zhi)品(pin)和傳統藥(yao)(yao)(yao)品(pin)的研發,經過多年(nian)來的不懈努力,西藏(zang)(zang)藥(yao)(yao)(yao)業已建成(cheng)一(yi)個(ge)國家(jia)級企業技術中心(xin)、三個(ge)符合GMP規范(fan)的藥(yao)(yao)(yao)品(pin)生產(chan)基(ji)地、一(yi)個(ge)符合GAP規范(fan)的藏(zang)(zang)藥(yao)(yao)(yao)材種植(zhi)基(ji)地,產(chan)品(pin)涵蓋(gai)生物制(zhi)品(pin)、藏(zang)(zang)藥(yao)(yao)(yao)、中藥(yao)(yao)(yao)和化學(xue)藥(yao)(yao)(yao)領(ling)域(yu),銷(xiao)售網絡遍(bian)及全國各省、自治區、直轄市(shi),依姆多的銷(xiao)售網絡更(geng)是遍(bian)及全球約40個(ge)國家(jia)和地區。
截止(zhi)2019年(nian)12月31日(ri),公(gong)(gong)(gong)(gong)司(si)(si)現有(you)(you)在職員(yuan)工500余人(ren),總資產27.67億元,實現年(nian)營業(ye)(ye)收入12.56億元。擁有(you)(you)西(xi)(xi)藏(zang)(zang)(zang)諾迪(di)康醫藥(yao)(yao)(yao)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、成都諾迪(di)康生(sheng)(sheng)物(wu)制(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、四川(chuan)諾迪(di)康威光(guang)制(zhi)藥(yao)(yao)(yao)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、西(xi)(xi)藏(zang)(zang)(zang)諾迪(di)康藏(zang)(zang)(zang)藥(yao)(yao)(yao)材開發有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、香港拓普瑞吉藥(yao)(yao)(yao)業(ye)(ye)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、西(xi)(xi)藏(zang)(zang)(zang)諾迪(di)康農業(ye)(ye)資源開發有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)和西(xi)(xi)藏(zang)(zang)(zang)氧道大健康生(sheng)(sheng)命科(ke)學有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)等下屬子公(gong)(gong)(gong)(gong)司(si)(si)。